|
|
Article: SkyePharma Announces FORADIL(R) CERTIHALER(TM) Launched in Germany.
- Article from:
- PR Newswire
- Article date:
- September 7, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LONDON, Sept. 7 /PRNewswire-FirstCall/ -- SkyePharma PLC announces today that its partner Novartis Pharma AG (Novartis) has launched FORADIL(R) CERTIHALER(TM) (formoterol fumarate inhalation powder) on the German market for the treatment of asthma and chronic obstructive pulmonary disease (COPD). The German pharmaceutical regulatory authority approved FORADIL(R) CERTIHALER(TM) in June. FORADIL(R) CERTIHALER(TM) is a trademark of Novartis. FORADIL(R) CERTIHALER(TM), co-developed by SkyePharma PLC and Novartis, was submitted for regulatory review in Europe on a country-by-country basis beginning in December 2002 and has now been approved in Switzerland, Austria, Finland, ...